Survivin as a Preferential Target for Cancer Therapy
Accessioned
2014-06-20T21:42:22ZAvailable
2014-06-20T21:42:22ZIssued
2014-02-13Metadata
Show full item recordCitation
Int. J. Mol. Sci. 2014, 15, 2494-2516; doi:10.3390/ijms15022494
Attribution 4.0 International